Impella

Aachen, Germany Founded: 1998 • Age: 28 yrs Acquired By Abiomed
Ventricular assist devices are provided for cardiac hemodynamic support.
Request Access

About Impella

Impella is a company based in Aachen (Germany) founded in 1998 was acquired by Abiomed in April 2005.. The company has 840 employees as of December 31, 2022. Impella operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.

  • Headquarter Aachen, Germany
  • Employees 840 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Abiomed, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    840

    as on Dec 31, 2022

  • Acquired by
    Abiomed

    (Apr 27, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Impella

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Impella

Impella has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abiomed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Heart pumps are developed for blood circulation and oxygenation support.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Impella

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Impella

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Impella Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Impella

Impella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of neuroprotection devices for carotid artery disease
domain founded_year HQ Location
Interventional devices for cardiovascular and vascular diseases are developed.
domain founded_year HQ Location
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
domain founded_year HQ Location
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
domain founded_year HQ Location
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
domain founded_year HQ Location
Catheter ablation treatments for atrial fibrillation are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Impella

Frequently Asked Questions about Impella

When was Impella founded?

Impella was founded in 1998.

Where is Impella located?

Impella is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.

How many employees does Impella have?

As of Dec 31, 2022, the latest employee count at Impella is 840.

What does Impella do?

Impella was founded in 1998 in Aachen, Germany, within the medical devices sector focused on cardiac care. Compact ventricular assist devices are developed and supplied to deliver hemodynamic support during procedures. These devices, smaller than a pencil in width, function as temporary heart pumps to maintain blood flow when native heart function is impaired, allowing recovery time. Operations emphasize innovation in minimally invasive cardiac solutions.

Who are the top competitors of Impella?
Who are Impella's investors?

Impella has 1 investor. Key investors include Abiomed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available